CTNM Earnings

Quarterly EPS
$-0.40
Q3 2024
$-0.56
Q4 2024
$-0.62
Q1 2025
$-0.62
Q2 2025
$-0.45
Q3 2025
$-0.49
Q4 2025
$-0.39
Q1 2026
$-0.40
Q2 2026
Latest RevenueN/A
Latest Net Income-15154000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.400-15154000+35.5%
Q1 2026-$0.390-14456000+37.1%
Q4 2025-$0.490-15156000+12.5%
Q3 2025-$0.450-12792000-12.5%
Q2 2025-$0.620-16040000-59.0%
Q1 2025-$0.620-15990000
Q4 2024-$0.560-14565000
Q3 2024-$0.400-10267000
Q2 2024-$0.390-9009000
Contineum Therapeutics (CTNM) — Earnings